tiprankstipranks
Spyre Therapeutics, Inc (SYRE)
:SYRE
US Market

Spyre Therapeutics (SYRE) Stock Investors

Compare
445 Followers
Based on 794,476 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold SYRE
On average, investors allocate 0.00% of their portfolios to SYRE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 794,476 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SYRE

3.0%
Last 7
Days
4.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SYRE, out of 794,476 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SYRE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.40%
$27.81
Reduced
<0.01%
$20.80
Based on the activity of investors who made their portfolios public
The table shows changes in SYRE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SYRE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.82%
-1.48%
-2.87%
2.68B
Healthcare
Riot Platforms
4.58%
-1.40%
-1.74%
2.56B
Financial
Abbott Laboratories
3.57%
-1.06%
-0.33%
228.29B
Healthcare
Nio
8.84%
-0.90%
-0.30%
7.66B
Consumer Cyclical
CVS Health
4.44%
-0.85%
-2.02%
85.12B
Healthcare
Citigroup
4.13%
-0.03%
+1.82%
118.67B
Financial
Bristol-Myers Squibb
3.55%
-0.41%
-1.15%
117.65B
Healthcare
Delta Air Lines
4.60%
+0.26%
+4.34%
25.01B
Industrials
Lucid Group
5.40%
+0.42%
+1.63%
7.03B
Consumer Cyclical
Merck & Company
3.07%
-1.04%
+1.30%
218.22B
Healthcare
Based on the activity of 794,476 active portfolios
Open your Smart Portfolio

SYRE Investor Analysis

SYRE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.3%
of SYRE holders
are under 35
Average Segment Performance
Average P/E Ratio17.86
Beta11.00
Dividend Yield3.91%
SYRE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.0%
of SYRE holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.98
Beta19.48
Dividend Yield3.42%
SYRE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.8%
of SYRE holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta12.14
Dividend Yield3.66%
Overview of age group and performance of SYRE stock investors
See who invests in SYRE according to age group and performance.

FAQ

How many retail Investors hold SYRE?
<0.1% of TipRanks' retail investors hold SYRE in their portfolios.
    What is SYRE Investor Sentiment?
    SYRE’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of SYRE in the last 7 days?
      ▲ 3.0% of TipRanks' retail investors changed their holding of SYRE in the last 7 days.
        What percentage of retail investors changed their holding of SYRE in the last 30 days?
        ▲ 4.3% of TipRanks' retail investors changed their holding of SYRE in the last 30 days.
          What is the average age of retail investors who hold SYRE?
          The average age of SYRE Holders is between 35–55.
            What other stocks have SYRE investors also bought?
            SYRE Investors also bought VKTX, RIOT, ABT, NIO, CVS, C, BMY, DAL, LCID, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              LCTXLineage Therap
              CNCCentene
              ELMDElectromed
              GSKGlaxoSmithKline
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis